1
|
Debbabi KF, Al-Harbi SA, Al-Saidi HM, Aljuhani EH, Felaly RN, Abd El-Gilil SM, Bashandy MS, Jannet HB. Synthesis, anticancer, antimicrobial, anti-tuberculosis and molecular docking of heterocyclic N-ethyl-N-methylbenzenesulfonamide derivatives. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2019.127423] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
2
|
Debbabi KF, Al-Harbi SA, Al-Saidi HM, Aljuhani EH, Abd El-Gilil SM, Bashandy MS. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase. J Enzyme Inhib Med Chem 2016; 31:7-19. [PMID: 27557134 DOI: 10.1080/14756366.2016.1217851] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
This article describes the synthesis of some novel heterocyclic sulfonamides having biologically active thiophene 3, 4, 5, 6, coumarin 8, benzocoumarin 9, thiazole 7, piperidine 10, pyrrolidine 11, pyrazole 14 and pyridine 12, 13. Starting with 4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)-N-ethyl-N-methylbenzenesulfonamide (2), which was prepared from condensation of acetophenone derivative 1 with 2-cyanoacetohydrazide. The structures of the newly synthesized compounds were confirmed by elemental analysis, IR, 1H NMR, 13C NMR, 19F NMR and MS spectral data. All the newly synthesized heterocyclic sulfonamides were evaluated as in-vitro anti-breast cancer cell line (MCF7) and as in-vitro antimicrobial agents. Compounds 8, 5 and 11 were more active than MTX reference drug and compounds 12, 7, 4, 14, 5 and 8 were highly potent against Klebsiella pneumonia. Molecular operating environment performed virtual screening using molecular docking studies of the synthesized compounds. The results indicated that some prepared compounds are suitable inhibitor against dihydrofolate reductase (DHFR) enzyme (PDBSD:4DFR) with further modification.
Collapse
Affiliation(s)
- Khaled F Debbabi
- a Department of Chemistry , University College in Al-Jamoum, Umm Al-Qura University , Makkah , Saudi Arabia.,b Laboratory of Heterocyclic Chemistry , Natural Products and Reactivity, Team: Medicinal Chemistry and Natural Products, Faculty of Science of Monastir, University of Monastir , Tunisia
| | - Sami A Al-Harbi
- a Department of Chemistry , University College in Al-Jamoum, Umm Al-Qura University , Makkah , Saudi Arabia
| | - Hamed M Al-Saidi
- a Department of Chemistry , University College in Al-Jamoum, Umm Al-Qura University , Makkah , Saudi Arabia
| | - Enas H Aljuhani
- c Department of Chemistry , College of Applied Science, Umm Al-Qura University , Makkah , Saudi Arabia
| | - Shimaa M Abd El-Gilil
- d Deparment of Organic Chemistry , Faculty of Pharmacy (Girls), Al-Azhar University, Nasr City, Cairo, Egypt , and
| | - Mahmoud S Bashandy
- a Department of Chemistry , University College in Al-Jamoum, Umm Al-Qura University , Makkah , Saudi Arabia.,e Chemistry Department, Faculty of Science (Boys), Al-Azhar University , Nasr City , Cairo , Egypt
| |
Collapse
|